Search research articles
Contact Us
Filters
Showing results (1101-1110 of 1,173) with videos related to
Page
of 118
Sort By:
Journal of Virology
|
January 11, 2001
Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif
M A Altfeld, B Livingston, N Reshamwala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 9, 2013
Phase I study of pazopanib in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study
Stephen I Shibata, Vincent Chung, Timothy W Synold, et al.
BMJ Open
|
February 16, 2020
Study protocol for a multisite randomised controlled trial of a rehabilitation intervention to reduce participation restrictions among female breast cancer survivors
Courtney J Stevens, Mark T Hegel, Marie Anne Bakitas, et al.
The American Naturalist
|
September 7, 2019
Understanding Maladaptation by Uniting Ecological and Evolutionary Perspectives
Steven P Brady, Daniel I Bolnick, Rowan D H Barrett, et al.
Nature Communications
|
February 17, 2019
A functional subset of CD8<sup>+</sup> T cells during chronic exhaustion is defined by SIRPα expression
Lara M Myers, Michal Caspi Tal, Laughing Bear Torrez Dulgeroff, et al.
Gastroenterology
|
November 13, 2019
Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer
Tej D Azad, Aadel A Chaudhuri, Penny Fang, et al.
Cancer Cell
|
October 6, 2023
Single-cell mapping identifies MSI<sup>+</sup> cells as a common origin for diverse subtypes of pancreatic cancer
Nirakar Rajbhandari, Michael Hamilton, Cynthia M Quintero, et al.
Blood Advances
|
November 10, 2025
A Phase I Study of Blinatumomab/Lenalidomide in Relapsed/Refractory B cell Lymphoma; Toxicity, Efficacy and Correlative Analysis
Joseph M Tuscano, Tamer Othman, Paul Frankel, et al.
Nature Communications
|
June 11, 2016
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
Jacob J Chabon, Andrew D Simmons, Alexander F Lovejoy, et al.
Blood Advances
|
September 11, 2023
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma
Ivana Spasevska, Ankush Sharma, Chloé B Steen, et al.
Page
of 118
Search research articles
Search
Showing results (1101-1110 of 1,173) with videos related to
Sort By:
Page
of 118
Journal of Virology
|
January 11, 2001
Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif
M A Altfeld, B Livingston, N Reshamwala, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 9, 2013
Phase I study of pazopanib in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study
Stephen I Shibata, Vincent Chung, Timothy W Synold, et al.
BMJ Open
|
February 16, 2020
Study protocol for a multisite randomised controlled trial of a rehabilitation intervention to reduce participation restrictions among female breast cancer survivors
Courtney J Stevens, Mark T Hegel, Marie Anne Bakitas, et al.
The American Naturalist
|
September 7, 2019
Understanding Maladaptation by Uniting Ecological and Evolutionary Perspectives
Steven P Brady, Daniel I Bolnick, Rowan D H Barrett, et al.
Nature Communications
|
February 17, 2019
A functional subset of CD8<sup>+</sup> T cells during chronic exhaustion is defined by SIRPα expression
Lara M Myers, Michal Caspi Tal, Laughing Bear Torrez Dulgeroff, et al.
Gastroenterology
|
November 13, 2019
Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer
Tej D Azad, Aadel A Chaudhuri, Penny Fang, et al.
Cancer Cell
|
October 6, 2023
Single-cell mapping identifies MSI<sup>+</sup> cells as a common origin for diverse subtypes of pancreatic cancer
Nirakar Rajbhandari, Michael Hamilton, Cynthia M Quintero, et al.
Blood Advances
|
November 10, 2025
A Phase I Study of Blinatumomab/Lenalidomide in Relapsed/Refractory B cell Lymphoma; Toxicity, Efficacy and Correlative Analysis
Joseph M Tuscano, Tamer Othman, Paul Frankel, et al.
Nature Communications
|
June 11, 2016
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
Jacob J Chabon, Andrew D Simmons, Alexander F Lovejoy, et al.
Blood Advances
|
September 11, 2023
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma
Ivana Spasevska, Ankush Sharma, Chloé B Steen, et al.
Page
of 118